<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "journalpublishing3.dtd">
<article xml:lang="en" article-type="research-article" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">IJMM</journal-id>
<journal-title-group>
<journal-title>International Journal of Molecular Medicine</journal-title></journal-title-group>
<issn pub-type="ppub">1107-3756</issn>
<issn pub-type="epub">1791-244X</issn>
<publisher>
<publisher-name>D.A. Spandidos</publisher-name></publisher></journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3892/ijmm.2017.2871</article-id>
<article-id pub-id-type="publisher-id">ijmm-39-03-0672</article-id>
<article-categories>
<subj-group>
<subject>Articles</subject></subj-group></article-categories>
<title-group>
<article-title>Antioxidant and cytoprotective effects of morin against hydrogen peroxide-induced oxidative stress are associated with the induction of Nrf-2-mediated HO-1 expression in V79-4 Chinese hamster lung fibroblasts</article-title></title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Lee</surname><given-names>Moon Hee</given-names></name><xref rid="af1-ijmm-39-03-0672" ref-type="aff">1</xref><xref rid="fn1-ijmm-39-03-0672" ref-type="author-notes">&#x0002A;</xref></contrib>
<contrib contrib-type="author">
<name><surname>Cha</surname><given-names>Hee-Jae</given-names></name><xref rid="af2-ijmm-39-03-0672" ref-type="aff">2</xref><xref rid="fn1-ijmm-39-03-0672" ref-type="author-notes">&#x0002A;</xref></contrib>
<contrib contrib-type="author">
<name><surname>Choi</surname><given-names>Eun Ok</given-names></name><xref rid="af1-ijmm-39-03-0672" ref-type="aff">1</xref></contrib>
<contrib contrib-type="author">
<name><surname>Han</surname><given-names>Min Ho</given-names></name><xref rid="af3-ijmm-39-03-0672" ref-type="aff">3</xref></contrib>
<contrib contrib-type="author">
<name><surname>Kim</surname><given-names>Sung Ok</given-names></name><xref rid="af4-ijmm-39-03-0672" ref-type="aff">4</xref></contrib>
<contrib contrib-type="author">
<name><surname>Kim</surname><given-names>Gi-Young</given-names></name><xref rid="af5-ijmm-39-03-0672" ref-type="aff">5</xref></contrib>
<contrib contrib-type="author">
<name><surname>Hong</surname><given-names>Su Hyun</given-names></name><xref rid="af6-ijmm-39-03-0672" ref-type="aff">6</xref></contrib>
<contrib contrib-type="author">
<name><surname>Park</surname><given-names>Cheol</given-names></name><xref rid="af7-ijmm-39-03-0672" ref-type="aff">7</xref></contrib>
<contrib contrib-type="author">
<name><surname>Moon</surname><given-names>Sung-Kwon</given-names></name><xref rid="af8-ijmm-39-03-0672" ref-type="aff">8</xref></contrib>
<contrib contrib-type="author">
<name><surname>Jeong</surname><given-names>Soon-Jeong</given-names></name><xref rid="af9-ijmm-39-03-0672" ref-type="aff">9</xref></contrib>
<contrib contrib-type="author">
<name><surname>Jeong</surname><given-names>Moon-Jin</given-names></name><xref rid="af10-ijmm-39-03-0672" ref-type="aff">10</xref></contrib>
<contrib contrib-type="author">
<name><surname>Kim</surname><given-names>Wun-Jae</given-names></name><xref rid="af11-ijmm-39-03-0672" ref-type="aff">11</xref><xref ref-type="corresp" rid="c1-ijmm-39-03-0672"/></contrib>
<contrib contrib-type="author">
<name><surname>Choi</surname><given-names>Yung Hyun</given-names></name><xref rid="af1-ijmm-39-03-0672" ref-type="aff">1</xref><xref rid="af6-ijmm-39-03-0672" ref-type="aff">6</xref><xref ref-type="corresp" rid="c2-ijmm-39-03-0672"/></contrib></contrib-group>
<aff id="af1-ijmm-39-03-0672">
<label>1</label>Anti-Aging Research Center, Dongeui University, Busan 614-714</aff>
<aff id="af2-ijmm-39-03-0672">
<label>2</label>Department of Parasitology and Genetics, Kosin University, College of Medicine, Busan 602-702</aff>
<aff id="af3-ijmm-39-03-0672">
<label>3</label>Natural Products Research Team, Marine Biodiversity Institute of Korea, Seocheon 325-902</aff>
<aff id="af4-ijmm-39-03-0672">
<label>4</label>Department of Food Science and Biotechnology, College of Engineering, Kyungsung University, Busan 608-736</aff>
<aff id="af5-ijmm-39-03-0672">
<label>5</label>Laboratory of Immunobiology, Department of Marine Life Sciences, Jeju National University, Jeju 690-756</aff>
<aff id="af6-ijmm-39-03-0672">
<label>6</label>Department of Biochemistry, Dongeui University College of Korean Medicine, Busan 614-052</aff>
<aff id="af7-ijmm-39-03-0672">
<label>7</label>Department of Molecular Biology, College of Natural Sciences and Human Ecology, Dongeui University, Busan 614-714</aff>
<aff id="af8-ijmm-39-03-0672">
<label>8</label>School of Food Science and Technology, Chung-Ang University, Anseong 456-756</aff>
<aff id="af9-ijmm-39-03-0672">
<label>9</label>Department of Dental Hygiene, College of Health Sciences, Youngsan University, Yangsan 626-790</aff>
<aff id="af10-ijmm-39-03-0672">
<label>10</label>Department of Oral Histology and Developmental Biology, School of Dentistry, Chosun University, Gwangju 501-759</aff>
<aff id="af11-ijmm-39-03-0672">
<label>11</label>Department of Urology, Chungbuk National University, College of Medicine and Institute for Tumor Research, Cheongju 362-763, Republic of Korea</aff>
<author-notes>
<corresp id="c1-ijmm-39-03-0672">Correspondence to: Professor Wun-Jae Kim, Department of Urology, Chungbuk National University, College of Medicine and Institute for Tumor Research, 7761 Sunhwan-ro, Seowon-gu, Cheongju 362-763, Republic of Korea, E-mail: <email>wjkim@chungbuk.ac.kr</email></corresp>
<corresp id="c2-ijmm-39-03-0672">Professor Yung Hyun Choi, Department of Biochemistry, Dongeui University College of Korean Medicine, 52-57 Yangjeong-ro, Busanjin, Busan 614-052, Republic of Korea, E-mail: <email>choiyh@deu.ac.kr</email></corresp><fn id="fn1-ijmm-39-03-0672">
<label>&#x0002A;</label>
<p>Contributed equally</p></fn></author-notes>
<pub-date pub-type="ppub">
<month>03</month>
<year>2017</year></pub-date>
<pub-date pub-type="epub">
<day>27</day>
<month>01</month>
<year>2017</year></pub-date>
<volume>39</volume>
<issue>3</issue>
<fpage>672</fpage>
<lpage>680</lpage>
<history>
<date date-type="received">
<day>20</day>
<month>09</month>
<year>2016</year></date>
<date date-type="accepted">
<day>16</day>
<month>01</month>
<year>2017</year></date></history>
<permissions>
<copyright-statement>Copyright &#x000A9; 2017, Spandidos Publications</copyright-statement>
<copyright-year>2017</copyright-year></permissions>
<abstract>
<p>Natural phytochemicals of plant origin, including flavonoids, have been found to be potent antioxidants providing beneficial effects against oxidative stress-related diseases. The present study was carried out to investigate the antioxidant properties of morin, a flavonoid originally isolated from the flowering plants of the Moraceae family. Superoxide dismutase (SOD)-like activity and 2,2&#x02032;-azino-bis-(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS<sup>&#x02022;+</sup>) radical scavenging activity were determined. We also investigated the cytoprotective effects of morin against hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>)-induced DNA damage and apoptosis in V79-4 Chinese hamster lung fibroblasts. Our results demonstrated that morin had strong scavenging effects against ABTS<sup>&#x02022;+</sup> radicals with enhanced SOD activity, which varied in a dose-dependent manner. Morin was found to reduce H<sub>2</sub>O<sub>2</sub>-induced intracellular reactive oxygen species generation and nuclear DNA damage, and it recovered cell viability damaged by H<sub>2</sub>O<sub>2</sub> via inhibition of mitochondrial dysfunction-mediated apoptosis. Notably, the treatment of V79-4 cells with morin markedly enhanced the expression of heme oxygenase-1 (HO-1) but not quinone oxidoreductase-1, which was associated with the increased expression and phosphorylation of nuclear factor-erythroid 2-related factor 2 (Nrf2) and the downregulation of Kelch-like ECH-associated protein 1 expression. Based on our findings, we conclude that morin effectively ameliorated oxidative stress-induced DNA damage through intrinsic free radical scavenging activity and activation of the Nrf2/HO-1 pathway.</p></abstract>
<kwd-group>
<kwd>morin</kwd>
<kwd>antioxidant</kwd>
<kwd>apoptosis</kwd>
<kwd>reactive oxygen species</kwd>
<kwd>Nrf2/HO-1</kwd></kwd-group></article-meta></front>
<body>
<sec sec-type="intro">
<title>Introduction</title>
<p>Oxidative stress reflects an imbalance between the production of reactive oxygen species (ROS) and the biological system's ability to remove them (<xref ref-type="bibr" rid="b1-ijmm-39-03-0672">1</xref>,<xref ref-type="bibr" rid="b2-ijmm-39-03-0672">2</xref>). Although some ROS act as cellular messengers in redox signaling, excessive ROS can arbitrarily react with all components of the cell, including proteins, lipids and DNA, thereby causing oxidative stress and damage in these macromolecules (<xref ref-type="bibr" rid="b3-ijmm-39-03-0672">3</xref>,<xref ref-type="bibr" rid="b4-ijmm-39-03-0672">4</xref>). This damage is a crucial etiological factor that is implicated in various human diseases, including aging and cancer, as well as neurodegenerative and chronic diseases (<xref ref-type="bibr" rid="b5-ijmm-39-03-0672">5</xref>,<xref ref-type="bibr" rid="b6-ijmm-39-03-0672">6</xref>). Therefore, the development of safe and effective antioxidants continues to be an important research target (<xref ref-type="bibr" rid="b7-ijmm-39-03-0672">7</xref>,<xref ref-type="bibr" rid="b8-ijmm-39-03-0672">8</xref>).</p>
<p>The antioxidant activity of natural compounds isolated from plants has been reported to counteract free radicals (<xref ref-type="bibr" rid="b9-ijmm-39-03-0672">9</xref>,<xref ref-type="bibr" rid="b10-ijmm-39-03-0672">10</xref>). Among such compounds, flavonoids, a family of well-known polyphenols, are bioactive compounds, which are widespread in plants and have long received attention in the development of antioxidants (<xref ref-type="bibr" rid="b8-ijmm-39-03-0672">8</xref>,<xref ref-type="bibr" rid="b11-ijmm-39-03-0672">11</xref>,<xref ref-type="bibr" rid="b12-ijmm-39-03-0672">12</xref>). Morin (2&#x02032;,3,4&#x02032;,5,7-pentahydroxyflavone), a member of the flavonoid family, is a yellow-colored compound that can be isolated from members of the Moraceae family, which are used as herbal medicines (<xref ref-type="bibr" rid="b13-ijmm-39-03-0672">13</xref>&#x02013;<xref ref-type="bibr" rid="b15-ijmm-39-03-0672">15</xref>). Morin exhibits certain biological activities, which include antioxidant (<xref ref-type="bibr" rid="b16-ijmm-39-03-0672">16</xref>&#x02013;<xref ref-type="bibr" rid="b18-ijmm-39-03-0672">18</xref>), cytoprotection (<xref ref-type="bibr" rid="b19-ijmm-39-03-0672">19</xref>,<xref ref-type="bibr" rid="b20-ijmm-39-03-0672">20</xref>), antidiabetic (<xref ref-type="bibr" rid="b21-ijmm-39-03-0672">21</xref>,<xref ref-type="bibr" rid="b22-ijmm-39-03-0672">22</xref>), anti-inflammatory (<xref ref-type="bibr" rid="b23-ijmm-39-03-0672">23</xref>&#x02013;<xref ref-type="bibr" rid="b25-ijmm-39-03-0672">25</xref>) and anticancer properties (<xref ref-type="bibr" rid="b26-ijmm-39-03-0672">26</xref>&#x02013;<xref ref-type="bibr" rid="b29-ijmm-39-03-0672">29</xref>). Moreover, morin has been reported to possess cellular protective effects against oxidative stress-induced damage through activation of the nuclear factor-erythroid 2-related factor 2 (Nrf2) signaling pathway (<xref ref-type="bibr" rid="b30-ijmm-39-03-0672">30</xref>&#x02013;<xref ref-type="bibr" rid="b32-ijmm-39-03-0672">32</xref>). However, the mechanism underlying the action of morin against oxidative stress has not been fully studied to date.</p>
<p>In the present study, the antioxidant activities of morin were examined through a series of <italic>in vitro</italic> tests that were conducted to examine its superoxide dismutase (SOD)-like and 2,2&#x02032;-azino-bis-(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS<sup>&#x02022;+</sup>) free radical scavenging activities. We also investigated the ameliorative effects of morin on cell damage induced by hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>) in V79-4 Chinese hamster lung fibroblasts and the possible mechanism underlying this cytoprotective effect.</p></sec>
<sec sec-type="materials|methods">
<title>Materials and methods</title>
<sec>
<title>Reagents and antibodies</title>
<p>Dulbecco's modified Eagle's medium (DMEM), fetal calf serum (FCS), streptomycin, and penicillin were purchased from WelGENE Inc. (Daegu, Republic of Korea). Morin, 3-(4,5-dimethylthiazol-2-yl&#x0005D;-2,5-diphenyltetrazolium bromide (MTT), 4&#x02032;,6-diamidino-2-phenylindole (DAPI), <italic>N</italic>-acetyl-L-cysteine (NAC), 6,6&#x02032;-tetrachloro-1,1&#x02032;,3,3&#x02032;-tetraethyl-imidacarbocyanine iodide (JC-1) and zinc protoporphyrin IX (ZnPP), a specific inhibitor of heme oxygenase-1 (HO-1), were obtained from Sigma-Aldrich Chemical Co. (St. Louis, MO, USA). A SOD assay kit was obtained from Dojindo Molecular Technologies (Tokyo, Japan). 2&#x02032;,7&#x02032;-Dichlorodihydrofluorescein diacetate (DCF-DA) and a fluorescein-conjugated Annexin V (Annexin V-FITC) staining assay kit were purchased from Molecular Probes (Eugene, OR, USA) and BD Biosciences (San Jose, CA, USA), respectively. An enhanced chemiluminescence (ECL) detection system was purchased from Amersham Co. (Arlington Heights, IL, USA). Primary antibodies (<xref rid="tI-ijmm-39-03-0672" ref-type="table">Table I</xref>) were purchased from Santa Cruz Biotechnology, Inc. (Dallas, TX, USA), Cell Signaling Technology, Inc. (Danvers, MA, USA) and Abcam, Inc. (Cambridge, MA, USA). Horseradish (HRP)-conjugated secondary antibodies were obtained from Amersham Co. Morin was dissolved in dimethyl sulphoxide (DMSO; Sigma-Aldrich Chemical Co.) and then diluted with medium to the desired concentration prior to use. The final DMSO concentration was &lt;0.1% in all experiments. All other chemicals were purchased from Sigma-Aldrich Chemical Co.</p></sec>
<sec>
<title>Measurement of SOD-like activity</title>
<p>The SOD-like activity of morin was measured using a SOD assay kit according to the manufacturer's instructions. Briefly, 20 <italic>&#x003BC;</italic>l of morin stock solution was added to 200 <italic>&#x003BC;</italic>l of the working solution in the SOD assay kit. The mixture was incubated at 37&#x000B0;C for 20 min after gentle shaking and then 20 <italic>&#x003BC;</italic>l of the kit enzyme working solution was added. The absorbance of the mixtures was measured at 450 nm using an enzyme-linked immunosorbent assay (ELISA) reader (Molecular Devices, Sunnyvale, CA, USA), and the SOD activity was calculated according to the manufacturer's instructions (<xref ref-type="bibr" rid="b33-ijmm-39-03-0672">33</xref>). Vitamin C was used as a positive control.</p></sec>
<sec>
<title>Measurement of ABTS radical scavenging activity</title>
<p>The ABTS assay was based on a previously described method (<xref ref-type="bibr" rid="b34-ijmm-39-03-0672">34</xref>) with slight modifications. ABTS radical cation (ABTS<sup>&#x02022;+</sup>) was produced by the reaction of a 7 mM ABTS solution with potassium persulphate (2.45 mM). The ABTS<sup>&#x02022;+</sup> solution was diluted with ethanol to an absorbance of 0.70&#x000B1;0.05 at 734 nm. The mixture was stored in the dark at room temperature for 12 h before use. After the addition of 25 <italic>&#x003BC;</italic>l of morin solution or vitamin C as a positive control to 2 ml of diluted ABTS<sup>&#x02022;+</sup> solution, absorbance was measured at 734 nm after exactly 6 min. Inhibition of the ABTS radical by morin was calculated using the formula: ABTS scavenging activity (%) = &#x0005B;1 - (absorbance of the sample/absorbance of the control)&#x0005D; &#x000D7; 100.</p></sec>
<sec>
<title>Cell culture</title>
<p>The Chinese hamster lung fibroblast V79-4 cell line was obtained from the American Type Culture Collection (ATCC; Manassas, MD, USA) and cultured in DMEM containing 10% heat-inactivated FCS, streptomycin (100 <italic>&#x003BC;</italic>g/ml) and penicillin (100 Units/ml). The cells were maintained at 37&#x000B0;C in an incubator with a humidified atmosphere of 5% CO<sub>2</sub>.</p></sec>
<sec>
<title>MTT assay</title>
<p>For the cell viability assay, V79-4 cells were seeded at 1&#x000D7;10<sup>5</sup> cells/ml in a 96-well plate and cultured for 24 h before being treated with the indicated concentrations of morin for 24 h in the presence or absence of 1 mM H<sub>2</sub>O<sub>2</sub> with or without 1 h pretreatment of morin or NAC. After the treatments, the MTT solution (0.5 mg/ml) was added, followed by a 2-h incubation at 37&#x000B0;C in the dark, after which the medium was removed. The formazan precipitate was dissolved in DMSO. The absorbance of the formazan product was measured at 540 nm using an ELISA reader (<xref ref-type="bibr" rid="b35-ijmm-39-03-0672">35</xref>).</p></sec>
<sec>
<title>Nuclear staining with DAPI</title>
<p>The cells were harvested, washed with PBS, and fixed with 3.7% paraformaldehyde for 30 min at room temperature. After washing twice with PBS, the cells were attached on glass slides using cytospin (Shandon, Pittsburgh, PA, USA) and stained with 2.5 <italic>&#x003BC;</italic>g/ml DAPI solution for 20 min at room temperature. The stained cells were washed twice with PBS and then analyzed using a fluorescence microscope (Carl Zeiss, Deisenhofen, Germany).</p></sec>
<sec>
<title>Determination of apoptotic cells by flow cytometry</title>
<p>To assess the induced cell apoptosis rate quantitatively, the cells were washed with PBS and stained with 5 <italic>&#x003BC;</italic>l of Annexin V-FITC and 5 <italic>&#x003BC;</italic>l of propidium iodide (PI) in each sample according to the manufacturer's protocols. After a 15-min incubation at room temperature in the dark, the degree of apoptosis was quantified as a percentage of the Annexin V-positive and PI-negative (Annexin V<sup>+</sup>/PI<sup>&#x02212;</sup>cells) cells using a flow cytometer (BD Biosciences).</p></sec>
<sec>
<title>Measurement of intracellular ROS</title>
<p>The oxidation-sensitive dye DCF-DA was used to determine the formation of intracellular ROS. Briefly, the cells from each treatment were harvested, washed twice with PBS, and then re-suspended in 10 <italic>&#x003BC;</italic>M DCF-DA for 30 min at 37&#x000B0;C in the dark. The production of ROS in the cells was monitored immediately using a flow cytometer (<xref ref-type="bibr" rid="b36-ijmm-39-03-0672">36</xref>).</p></sec>
<sec>
<title>Measurement of mitochondrial membrane potential (MMP, &#x00394;&#x003C8;m)</title>
<p>The MMP values were determined using the dual-emission potential-sensitive probe JC-1. Briefly, the cells were collected and incubated with 10 <italic>&#x003BC;</italic>M of JC-1 for 20 min at 37&#x000B0;C in the dark. After the JC-1 was removed, the cells were washed with PBS to remove the unbound dye, and the amount of JC-1 retained by 10,000 cells per sample was measured by using a flow cytometer (<xref ref-type="bibr" rid="b37-ijmm-39-03-0672">37</xref>).</p></sec>
<sec>
<title>Determination of DNA damage by comet assay</title>
<p>After each treatment, the cells were washed with PBS, and the cell suspension was mixed with 0.5% low melting agarose (LMA) at 37&#x000B0;C before adding it to the slides precoated with 1.0% normal melting agarose. After the agarose was solidified, the slides were covered with another 0.5% LMA and then immersed in lysis buffer &#x0005B;2.5 M NaCl, 500 mM Na-ethylenediaminetetraacetic acid (EDTA), 1 M Tris buffer, 1% sodium lauroyl sarcosinate and 1% Triton X-100&#x0005D; for 1 h at 4&#x000B0;C. The slides were later transferred into an unwinding buffer for another 20 min for DNA unwinding. The slides were then placed in an electrophoresis tank containing 300 mM NaOH and 1 mM Na-EDTA (pH 13.0). An electrical field was then applied (300 mA, 25 V) for 20 min at 25&#x000B0;C to draw the negatively charged DNA toward the anode. The slides were washed three times for 5 min at 25&#x000B0;C in a neutral-izing buffer (0.4 M Tris, pH 7.5), and then stained with 20 <italic>&#x003BC;</italic>g/ml PI. The slides were examined under a fluorescence microscope.</p></sec>
<sec>
<title>Protein extraction and western blot analysis</title>
<p>All cell lysates were lysed in an extraction buffer &#x0005B;25 mM Tris-Cl (pH 7.5), 250 mM NaCl, 5 mM EDTA, 1% Nonidet P-40, 0.1 mM sodium orthovanadate, 2 <italic>&#x003BC;</italic>g/ml leupeptin, and 100 <italic>&#x003BC;</italic>g/ml phenylmethylsulfonyl fluoride&#x0005D;. The protein concentration in the cell lysate was determined using a detergent-compatible protein assay from Bio-Rad (Hercules, CA, USA). In the Western blot analysis, equal amounts of protein (30&#x02013;50 <italic>&#x003BC;</italic>g) were separated by 8&#x02013;10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and then were electro-transferred to polyvinylidene fluoride (PVDF) membranes (Schleicher &amp; Schuell, Keene, NH, USA). The membranes were blocked with 5% skim milk for 1 h and then subjected to immunoblot analysis with the appropriate antibodies. Using an ECL detection system, immunoreactive bands were detected and exposed to X-ray film.</p></sec>
<sec>
<title>HO-1 activity assay</title>
<p>HO-1 enzyme activity was measured as previously described (<xref ref-type="bibr" rid="b38-ijmm-39-03-0672">38</xref>). In brief, lysates of the cells were prepared, and homogenates containing biliverdin reductase were obtained from rat liver. After quantifying the protein concentration, the cell lysates and homogenates were incubated with nicotinamide adenine dinucleotide phosphate (NADPH) and hemin for 1 h, whereas the blank samples were incubated with hemin only. The concentration of bilirubin, which was the product of degradation by HO-1, was determined as the difference in absorbance at 464 and 530 nm using an ELISA plate reader. HO-1 activity was expressed as picomoles of bilirubin per milligram of protein.</p></sec>
<sec>
<title>Statistical analysis</title>
<p>All experiments were conducted in triplicate (n=3), and a one-way ANOVA (SPSS 11.5 statistical software; SPSS, Inc., Chicago, IL, USA) was used to compare the mean values of each treatment. Significant differences were determined using Duncan's test. P&lt;0.05 was considered to indicate a statistically significant difference.</p></sec></sec>
<sec sec-type="results">
<title>Results</title>
<sec>
<title>Antioxidant activity of morin</title>
<p>To determine the antioxidant activity of morin, the SOD-like enzyme and ABTS radical scavenging activities were evaluated. As shown in <xref rid="f1-ijmm-39-03-0672" ref-type="fig">Fig. 1A</xref>, the SOD-like enzyme activity of morin was highly increased in a concentration-dependent manner to the given concentration. For example, the percentage of SOD-like enzyme activity was ~72% at a concentration of 100 <italic>&#x003BC;</italic>M morin, which was very similar after treatment with the same concentration of vitamin C used as a positive control. Similar to SOD-like enzyme activity, at different concentrations (10&#x02013;1,000 <italic>&#x003BC;</italic>M), morin was also found to effectively scavenge ABTS<sup>&#x02022;+</sup> (<xref rid="f1-ijmm-39-03-0672" ref-type="fig">Fig. 1B</xref>).</p></sec>
<sec>
<title>Morin protects against H<sub>2</sub>O<sub>2</sub>-induced inhibition of cell viability in V79-4 fibroblasts</title>
<p>To exclude the cytotoxicity caused by morin treatment in V79-4 fibroblasts, the cells were treated with different concentrations (100&#x02013;1,000 <italic>&#x003BC;</italic>M) of morin for 24 h. The MTT assay indicated that the treatments did not result in any cytotoxic effect at the concentration of 500 <italic>&#x003BC;</italic>M, and cell viability was significantly decreased at concentrations higher than 1,000 <italic>&#x003BC;</italic>M (<xref rid="f2-ijmm-39-03-0672" ref-type="fig">Fig. 2A</xref>). Therefore, 500 <italic>&#x003BC;</italic>M morin was selected for use in the subsequent examination of the protective effect of morin on H<sub>2</sub>O<sub>2</sub>-induced cytotoxicity. A further MTT assay revealed that treatment with 1 mM H<sub>2</sub>O<sub>2</sub> significantly reduced cell viability. However, the H<sub>2</sub>O<sub>2</sub>-induced reduction in cell viability was effectively protected by pretreatment with both 500 <italic>&#x003BC;</italic>M morin and 10 mM NAC (<xref rid="f2-ijmm-39-03-0672" ref-type="fig">Fig. 2B</xref>).</p></sec>
<sec>
<title>Morin attenuates H<sub>2</sub>O<sub>2</sub>-induced apoptosis in V79-4 fibroblasts</title>
<p>To elucidate the cytoprotective effect of morin against the H<sub>2</sub>O<sub>2</sub>-induced reduction in V79-4 cell viability, we investigated the effects of morin on H<sub>2</sub>O<sub>2</sub>-mediated apoptosis. The results of the DAPI staining showed that treatment with H<sub>2</sub>O<sub>2</sub> alone significantly increased the number of cells with condensed or blebbing nuclei. In contrast, when these cells were pretreated with morin or NAC, these phenomena were markedly reduced (<xref rid="f3-ijmm-39-03-0672" ref-type="fig">Fig. 3A</xref>). The results of the flow cytometry consistently indicated that the H<sub>2</sub>O<sub>2</sub> treatment enhanced the population of Annexin V<sup>+</sup>/PI<sup>&#x02212;</sup> apoptotic cells. However, the pretreatment of cells with morin or NAC prior to exposure to H<sub>2</sub>O<sub>2</sub> effectively protected the V79-4 cells against apoptosis (<xref rid="f3-ijmm-39-03-0672" ref-type="fig">Fig. 3B</xref>).</p></sec>
<sec>
<title>Morin suppresses H<sub>2</sub>O<sub>2</sub>-induced ROS generation in V79-4 fibroblasts</title>
<p>In a further experiment to study the mechanisms underlying the protective effect of morin, the intracellular ROS levels were determined. The results of the flow cytometric analysis using DCF-DA as a fluorescence probe demonstrated that the intensity of the DCF-liberated fluorescent signal from the H<sub>2</sub>O<sub>2</sub>-treated cells was markedly increased. However, the signal was effectively attenuated in the presence of morin as well as NAC (<xref rid="f4-ijmm-39-03-0672" ref-type="fig">Fig. 4A</xref>).</p></sec>
<sec>
<title>Morin inhibits H<sub>2</sub>O<sub>2</sub>-induced mitochondrial dysfunction and activation of caspase-3 in V79-4 fibroblasts</title>
<p>The mitochondrial-mediated intrinsic apoptosis pathway is initiated by the loss of mitochondrial membrane potential (MMP, &#x00394;&#x003C8;m) and the subsequent release of pro-apoptotic proteins, which leads to the activation of caspase-9 and -3 (<xref ref-type="bibr" rid="b39-ijmm-39-03-0672">39</xref>,<xref ref-type="bibr" rid="b40-ijmm-39-03-0672">40</xref>). We therefore investigated the effects of morin on the H<sub>2</sub>O<sub>2</sub>-induced loss of MMP and the activation of caspase-3. The results indicated that the loss of MMP in H<sub>2</sub>O<sub>2</sub>-treated V79-4 cells increased 6.4-fold relative to the untreated control; however, the reduction in MMP was significantly inhibited by pretreatment with morin (<xref rid="f4-ijmm-39-03-0672" ref-type="fig">Fig. 4B</xref>). The immunoblotting results indicated a marked increase in the level of activated caspase-3 expression in the H<sub>2</sub>O<sub>2</sub>-treated cells compared with the control. A subsequent increase in cleaved poly(ADP-ribose) polymerase (PARP), a well-known substrate of caspase-3 (<xref ref-type="bibr" rid="b41-ijmm-39-03-0672">41</xref>), was also observed. However, the results clearly showed that H<sub>2</sub>O<sub>2</sub>-induced caspase-3 activation and PARP degradation were completely abrogated by pretreatment with morin (<xref rid="f4-ijmm-39-03-0672" ref-type="fig">Fig. 4C</xref>).</p></sec>
<sec>
<title>Morin protects against H<sub>2</sub>O<sub>2</sub>-induced DNA damage in V79-4 fibroblasts</title>
<p>We then assessed the protective effects of morin against H<sub>2</sub>O<sub>2</sub>-induced DNA damage by applying the alkaline comet assay and Western blot analysis. The comet assay measures single- and double-strand breaks that are caused either directly by the DNA-damaging system or indirectly by the repair mechanism (<xref ref-type="bibr" rid="b42-ijmm-39-03-0672">42</xref>). As shown in <xref rid="f5-ijmm-39-03-0672" ref-type="fig">Fig. 5A</xref>, the exposure of cells to H<sub>2</sub>O<sub>2</sub> increased DNA breaks, resulting in an increase in fluorescence intensity in the tails of the comet-like structures. However, pretreatment with morin led to a marked decrease in damage to DNA (<xref rid="f5-ijmm-39-03-0672" ref-type="fig">Fig. 5A</xref>). Furthermore, as expected, H<sub>2</sub>O<sub>2</sub> enhanced the phosphorylation of histone &#x003BB;H2AX on serine 139, which was rapidly increased after the induction of DNA double-strand breaks (<xref ref-type="bibr" rid="b43-ijmm-39-03-0672">43</xref>), whereas pretreatment with morin prevented the increase in the phosphorylation of histone &#x003BB;H2AX (<xref rid="f5-ijmm-39-03-0672" ref-type="fig">Fig. 5B</xref>).</p></sec>
<sec>
<title>Morin enhances the expression Nrf2 and HO-1 in V79-4 fibro- blasts</title>
<p>The transcription factor Nrf2 regulates the expression of antioxidant responsive element (ARE)-driven antioxidant and cytoprotective genes, including HO-1 and quinone oxidoreductase-1 (NQO-1), to control the cellular defense against oxidative stress (<xref ref-type="bibr" rid="b44-ijmm-39-03-0672">44</xref>,<xref ref-type="bibr" rid="b45-ijmm-39-03-0672">45</xref>). Thus, we examined the effects of morin on the levels of Nrf2, HO-1 and NQO-1 expression, and found that treatment with morin gradually increased Nrf2 expression and its phosphorylation, but not NQO-1 expression, in a time-dependent manner. It concomitantly decreased the level of Kelch-like ECH-associated protein 1 (Keap1), which is a negative regulator of Nrf2 (<xref rid="f6-ijmm-39-03-0672" ref-type="fig">Fig. 6A</xref>). Morin also enhanced HO-1 expression as well as HO-1 activity in a time-dependent manner (<xref rid="f6-ijmm-39-03-0672" ref-type="fig">Fig. 6B</xref>).</p></sec>
<sec>
<title>The Nrf2/HO-1 pathway is involved in the protective effects of morin in H<sub>2</sub>O<sub>2</sub>-treated V79-4 fibroblasts</title>
<p>To determine whether the morin-induced antioxidant and cytoprotective activities against oxidative stress were mediated through the activation of the Nrf2/HO-1 pathway, V79-4 cells were pretreated with or without a specific inhibitor of HO-1, ZnPP, and the levels of ROS and cell viability were assessed. As shown in <xref rid="f7-ijmm-39-03-0672" ref-type="fig">Fig. 7</xref>, ZnPP abrogated the protective effect of morin on the H<sub>2</sub>O<sub>2</sub>-induced production of ROS and the reduction in cell viability.</p></sec></sec>
<sec sec-type="discussion">
<title>Discussion</title>
<p>Oxidative stress, represented as the increase in ROS, is an abnormal phenomenon when the production of free radicals exceeds the antioxidant capacity. Extreme increases in ROS can destroy the cytoprotective defense mechanism by the emasculation of antioxidant systems, leading to the development of several human diseases (<xref ref-type="bibr" rid="b5-ijmm-39-03-0672">5</xref>,<xref ref-type="bibr" rid="b6-ijmm-39-03-0672">6</xref>). The accumulation of ROS directly causes base modification and DNA strand breaks, resulting in DNA damage (<xref ref-type="bibr" rid="b3-ijmm-39-03-0672">3</xref>,<xref ref-type="bibr" rid="b4-ijmm-39-03-0672">4</xref>). Accumulation of ROS also induces mitochondrial dysfunction, resulting in a decrease in MMP, and activation of caspase-9 and -3 through the release of mitochondrial apoptotic factors into the cytoplasm. These factors are known to be strong stimulators of the mitochondrial-mediated intrinsic apoptosis pathway (<xref ref-type="bibr" rid="b46-ijmm-39-03-0672">46</xref>,<xref ref-type="bibr" rid="b47-ijmm-39-03-0672">47</xref>). In the present study, the results showed that morin had a strong antioxidant capacity as determined by SOD-like activity and ABTS scavenging ability assays, which are widely used to analyze the antioxidant potential of candidate materials. Additional data from the MTT assay and flow cytometry demonstrated that morin significantly rescued cell viability and reduced the apoptosis caused by H<sub>2</sub>O<sub>2</sub>-induced oxidative stress in V79-4 lung fibroblasts. We also found that the protective effects were associated with the suppression of ROS accumulation and DNA damage, which indicates that morin may enhance the antioxidant and DNA repair systems. In addition, the results of the JC-1 staining and immunoblotting showed that morin significantly restored the H<sub>2</sub>O<sub>2</sub>-induced loss of MMP at the basal level, the activation of caspase-3, and the cleavage of PARP, which is a substrate protein of activated caspase-3 (<xref ref-type="bibr" rid="b41-ijmm-39-03-0672">41</xref>) in V79-4 cells. These results indicate that the ability of morin to attenuate oxidative stress was partly dependent on inhibition of mitochondrial-related apoptosis.</p>
<p>Previous evidence strongly suggests that the Nrf2-mediated signaling pathway is essential in protecting cells against oxidative stress. Nrf2, a basic leucine zipper transcription factor, plays an important role in the transcriptional regulation of phase II enzymes by binding to AREs (<xref ref-type="bibr" rid="b44-ijmm-39-03-0672">44</xref>,<xref ref-type="bibr" rid="b45-ijmm-39-03-0672">45</xref>). Under basal conditions, Nrf2-dependent transcription is suppressed by Keap1, a negative regulator of Nrf2, which facilitates the degradation of Nrf2 through ubiquitin-mediated proteasomal degradation (<xref ref-type="bibr" rid="b45-ijmm-39-03-0672">45</xref>,<xref ref-type="bibr" rid="b48-ijmm-39-03-0672">48</xref>). Upon the modification of specific thiols by insult, Keap1 triggers the dissociation of Nrf2 from the Nrf2-Keap1 complex in the cytoplasm and allows Nrf2 to translocate into the nucleus, where it subsequently activates the AREs present in the promoter regions of an array of genes (<xref ref-type="bibr" rid="b44-ijmm-39-03-0672">44</xref>,<xref ref-type="bibr" rid="b48-ijmm-39-03-0672">48</xref>). Moreover, several previous studies have found that the phosphorylation of Nrf2 (Try568) led to the nuclear export of Nrf2 (<xref ref-type="bibr" rid="b49-ijmm-39-03-0672">49</xref>,<xref ref-type="bibr" rid="b50-ijmm-39-03-0672">50</xref>). Therefore, we investigated the Nrf2 pathway to determine whether it contributes to the protective effects of morin against H<sub>2</sub>O<sub>2</sub>-induced oxidative stress. In the present study, our results strongly support the ability of morin to stimulate the Nrf2 pathway; morin treatment increased Nrf2 accumulation and phosphorylation and decreased Keap1 expression in a time-dependent manner. Following the treatment of V79-4 cells with morin, we also observed significant increases in HO-1 expression and activity, while NQO1 was unaffected by the morin treatment. HO-1 is an Nrf2 downstream target and a powerful indirect antioxidant enzyme, which is a rate-limiting enzyme in heme catabolism. This enzyme converts heme to beneficial byproducts such as carbon monoxide and bilirubin, which can directly scavenge free radicals and repair DNA damage caused by oxidative stress (<xref ref-type="bibr" rid="b48-ijmm-39-03-0672">48</xref>). However, pretreatment with ZnPP, an inhibitor of HO-1, markedly abrogated the protective effects of morin against H<sub>2</sub>O<sub>2</sub>-induced MMP loss and inhibition of the growth of the V79-4 cells (<xref rid="f7-ijmm-39-03-0672" ref-type="fig">Fig. 7</xref>). Therefore, our results support the supposition that the cytoprotective effect of morin against oxidative stress in V79-4 cells is mediated through activation of the Nrf2/HO-1 signaling pathway.</p>
<p>In conclusion, the present study provides evidence that morin protects lung fibroblast V79-4 cells from oxidative stress-induced DNA damage and cell death via the suppression of ROS generation and mitochondrial dysfunction. This process is also associated with the involvement of Nrf2 activation and the upregulation of the expression of its downstream antioxidant gene HO-1 in order to protect cells from oxidative stress. Therefore, morin may be of therapeutic value in the prevention and treatment of various human diseases associated with oxidative stress.</p></sec></body>
<back>
<ack>
<title>Acknowledgments</title>
<p>This study was supported by the Functional Districts of the Science Belt Support Program, Ministry of Science, ICT and Future Planning and Basic Science Research Program through a grant from the National Research Foundation of Korea (NRF) funded by the Korea government (no. 2015R1A2A2A01004633).</p></ack>
<ref-list>
<title>References</title>
<ref id="b1-ijmm-39-03-0672"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dr&#x000F6;ge</surname><given-names>W</given-names></name></person-group><article-title>Free radicals in the physiological control of cell function</article-title><source>Physiol Rev</source><volume>82</volume><fpage>47</fpage><lpage>95</lpage><year>2002</year><pub-id pub-id-type="doi">10.1152/physrev.00018.2001</pub-id><pub-id pub-id-type="pmid">11773609</pub-id></element-citation></ref>
<ref id="b2-ijmm-39-03-0672"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lyakhovich</surname><given-names>A</given-names></name><name><surname>Graifer</surname><given-names>D</given-names></name></person-group><article-title>Mitochondria-mediated oxidative stress: Old Target for New drugs</article-title><source>Curr Med Chem</source><volume>22</volume><fpage>3040</fpage><lpage>3053</lpage><year>2015</year><pub-id pub-id-type="doi">10.2174/0929867322666150729114036</pub-id><pub-id pub-id-type="pmid">26219394</pub-id></element-citation></ref>
<ref id="b3-ijmm-39-03-0672"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ermakov</surname><given-names>AV</given-names></name><name><surname>Konkova</surname><given-names>MS</given-names></name><name><surname>Kostyuk</surname><given-names>SV</given-names></name><name><surname>Izevskaya</surname><given-names>VL</given-names></name><name><surname>Baranova</surname><given-names>A</given-names></name><name><surname>Veiko</surname><given-names>NN</given-names></name></person-group><article-title>Oxidized extracellular DNA as a stress signal in human cells</article-title><source>Oxid Med Cell Longev</source><volume>2013</volume><fpage>649747</fpage><year>2013</year><pub-id pub-id-type="doi">10.1155/2013/649747</pub-id><pub-id pub-id-type="pmid">23533696</pub-id><pub-id pub-id-type="pmcid">3606786</pub-id></element-citation></ref>
<ref id="b4-ijmm-39-03-0672"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>HY</given-names></name><name><surname>Lee</surname><given-names>TH</given-names></name></person-group><article-title>Antioxidant enzymes as redox-based biomarkers: A brief review</article-title><source>BMB Rep</source><volume>48</volume><fpage>200</fpage><lpage>208</lpage><year>2015</year><pub-id pub-id-type="doi">10.5483/BMBRep.2015.48.4.274</pub-id><pub-id pub-id-type="pmid">25560698</pub-id><pub-id pub-id-type="pmcid">4436855</pub-id></element-citation></ref>
<ref id="b5-ijmm-39-03-0672"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alfadda</surname><given-names>AA</given-names></name><name><surname>Sallam</surname><given-names>RM</given-names></name></person-group><article-title>Reactive oxygen species in health and disease</article-title><source>J Biomed Biotechnol</source><volume>2012</volume><fpage>936486</fpage><year>2012</year><pub-id pub-id-type="doi">10.1155/2012/936486</pub-id><pub-id pub-id-type="pmid">22927725</pub-id><pub-id pub-id-type="pmcid">3424049</pub-id></element-citation></ref>
<ref id="b6-ijmm-39-03-0672"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cha</surname><given-names>MY</given-names></name><name><surname>Kim</surname><given-names>DK</given-names></name><name><surname>Mook-Jung</surname><given-names>I</given-names></name></person-group><article-title>The role of mitochondrial DNA mutation on neurodegenerative diseases</article-title><source>Exp Mol Med</source><volume>47</volume><fpage>e150</fpage><year>2015</year><pub-id pub-id-type="doi">10.1038/emm.2014.122</pub-id><pub-id pub-id-type="pmid">25766619</pub-id><pub-id pub-id-type="pmcid">4351410</pub-id></element-citation></ref>
<ref id="b7-ijmm-39-03-0672"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ginter</surname><given-names>E</given-names></name><name><surname>Simko</surname><given-names>V</given-names></name><name><surname>Panakova</surname><given-names>V</given-names></name></person-group><article-title>Antioxidants in health and disease</article-title><source>Bratisl Lek Listy</source><volume>115</volume><fpage>603</fpage><lpage>606</lpage><year>2014</year></element-citation></ref>
<ref id="b8-ijmm-39-03-0672"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cirillo</surname><given-names>G</given-names></name><name><surname>Curcio</surname><given-names>M</given-names></name><name><surname>Vittorio</surname><given-names>O</given-names></name><name><surname>Iemma</surname><given-names>F</given-names></name><name><surname>Restuccia</surname><given-names>D</given-names></name><name><surname>Spizzirri</surname><given-names>UG</given-names></name><name><surname>Puoci</surname><given-names>F</given-names></name><name><surname>Picci</surname><given-names>N</given-names></name></person-group><article-title>Polyphenol conjugates and human health: A perspective review</article-title><source>Crit Rev Food Sci Nutr</source><volume>56</volume><fpage>326</fpage><lpage>337</lpage><year>2016</year><pub-id pub-id-type="doi">10.1080/10408398.2012.752342</pub-id></element-citation></ref>
<ref id="b9-ijmm-39-03-0672"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Landete</surname><given-names>JM</given-names></name></person-group><article-title>Dietary intake of natural antioxidants: Vitamins and polyphenols</article-title><source>Crit Rev Food Sci Nutr</source><volume>53</volume><fpage>706</fpage><lpage>721</lpage><year>2013</year><pub-id pub-id-type="doi">10.1080/10408398.2011.555018</pub-id><pub-id pub-id-type="pmid">23638931</pub-id></element-citation></ref>
<ref id="b10-ijmm-39-03-0672"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kehrer</surname><given-names>JP</given-names></name><name><surname>Klotz</surname><given-names>LO</given-names></name></person-group><article-title>Free radicals and related reactive species as mediators of tissue injury and disease: Implications for Health</article-title><source>Crit Rev Toxicol</source><volume>45</volume><fpage>765</fpage><lpage>798</lpage><year>2015</year><pub-id pub-id-type="doi">10.3109/10408444.2015.1074159</pub-id><pub-id pub-id-type="pmid">26610815</pub-id></element-citation></ref>
<ref id="b11-ijmm-39-03-0672"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kancheva</surname><given-names>VD</given-names></name><name><surname>Kasaikina</surname><given-names>OT</given-names></name></person-group><article-title>Bio-antioxidants - a chemical base of their antioxidant activity and beneficial effect on human health</article-title><source>Curr Med Chem</source><volume>20</volume><fpage>4784</fpage><lpage>4805</lpage><year>2013</year><pub-id pub-id-type="doi">10.2174/09298673113209990161</pub-id><pub-id pub-id-type="pmid">24274817</pub-id></element-citation></ref>
<ref id="b12-ijmm-39-03-0672"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bondonno</surname><given-names>CP</given-names></name><name><surname>Croft</surname><given-names>KD</given-names></name><name><surname>Ward</surname><given-names>N</given-names></name><name><surname>Considine</surname><given-names>MJ</given-names></name><name><surname>Hodgson</surname><given-names>JM</given-names></name></person-group><article-title>Dietary flavonoids and nitrate: Effects on nitric oxide and vascular function</article-title><source>Nutr Rev</source><volume>73</volume><fpage>216</fpage><lpage>235</lpage><year>2015</year><pub-id pub-id-type="doi">10.1093/nutrit/nuu014</pub-id><pub-id pub-id-type="pmid">26024545</pub-id></element-citation></ref>
<ref id="b13-ijmm-39-03-0672"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stockert</surname><given-names>JC</given-names></name><name><surname>Colman</surname><given-names>OD</given-names></name><name><surname>Ca&#x000F1;ete</surname><given-names>M</given-names></name></person-group><article-title>Fluorescence reaction of leukocyte granules by morin</article-title><source>Acta Histochem Suppl</source><volume>31</volume><fpage>243</fpage><lpage>252</lpage><year>1985</year><pub-id pub-id-type="pmid">2410949</pub-id></element-citation></ref>
<ref id="b14-ijmm-39-03-0672"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Srinivas</surname><given-names>NR</given-names></name></person-group><article-title>Recent trends in preclinical drug-drug interaction studies of flavonoids - Review of case studies, issues and perspectives</article-title><source>Phytother Res</source><volume>29</volume><fpage>1679</fpage><lpage>1691</lpage><year>2015</year><pub-id pub-id-type="doi">10.1002/ptr.5447</pub-id><pub-id pub-id-type="pmid">26343418</pub-id></element-citation></ref>
<ref id="b15-ijmm-39-03-0672"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Caselli</surname><given-names>A</given-names></name><name><surname>Cirri</surname><given-names>P</given-names></name><name><surname>Santi</surname><given-names>A</given-names></name><name><surname>Paoli</surname><given-names>P</given-names></name></person-group><article-title>Morin: A Promising natural drug</article-title><source>Curr Med Chem</source><volume>23</volume><fpage>774</fpage><lpage>791</lpage><year>2016</year><pub-id pub-id-type="doi">10.2174/0929867323666160106150821</pub-id></element-citation></ref>
<ref id="b16-ijmm-39-03-0672"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>JM</given-names></name><name><surname>Lee</surname><given-names>EK</given-names></name><name><surname>Park</surname><given-names>G</given-names></name><name><surname>Kim</surname><given-names>MK</given-names></name><name><surname>Yokozawa</surname><given-names>T</given-names></name><name><surname>Yu</surname><given-names>BP</given-names></name><name><surname>Chung</surname><given-names>HY</given-names></name></person-group><article-title>Morin modulates the oxidative stress-induced NF-kappaB pathway through its anti-oxidant activity</article-title><source>Free Radic Res</source><volume>44</volume><fpage>454</fpage><lpage>461</lpage><year>2010</year><pub-id pub-id-type="doi">10.3109/10715761003610737</pub-id><pub-id pub-id-type="pmid">20187708</pub-id></element-citation></ref>
<ref id="b17-ijmm-39-03-0672"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Komirishetty</surname><given-names>P</given-names></name><name><surname>Areti</surname><given-names>A</given-names></name><name><surname>Sistla</surname><given-names>R</given-names></name><name><surname>Kumar</surname><given-names>A</given-names></name></person-group><article-title>Morin mitigates chronic constriction injury (CCI)-induced peripheral neuropathy by inhibiting oxidative stress induced PARP over-activation and neuroinflammation</article-title><source>Neurochem Res</source><volume>41</volume><fpage>2029</fpage><lpage>2042</lpage><year>2016</year><pub-id pub-id-type="doi">10.1007/s11064-016-1914-0</pub-id><pub-id pub-id-type="pmid">27084773</pub-id></element-citation></ref>
<ref id="b18-ijmm-39-03-0672"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ola</surname><given-names>MS</given-names></name><name><surname>Aleisa</surname><given-names>AM</given-names></name><name><surname>Al-Rejaie</surname><given-names>SS</given-names></name><name><surname>Abuohashish</surname><given-names>HM</given-names></name><name><surname>Parmar</surname><given-names>MY</given-names></name><name><surname>Alhomida</surname><given-names>AS</given-names></name><name><surname>Ahmed</surname><given-names>MM</given-names></name></person-group><article-title>Flavonoid, morin inhibits oxidative stress, inflammation and enhances neurotrophic support in the brain of streptozotocin-induced diabetic rats</article-title><source>Neurol Sci</source><volume>35</volume><fpage>1003</fpage><lpage>1008</lpage><year>2014</year><pub-id pub-id-type="doi">10.1007/s10072-014-1628-5</pub-id><pub-id pub-id-type="pmid">24413816</pub-id></element-citation></ref>
<ref id="b19-ijmm-39-03-0672"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>MadanKumar</surname><given-names>P</given-names></name><name><surname>NaveenKumar</surname><given-names>P</given-names></name><name><surname>Manikandan</surname><given-names>S</given-names></name><name><surname>Devaraj</surname><given-names>H</given-names></name><name><surname>NiranjaliDevaraj</surname><given-names>S</given-names></name></person-group><article-title>Morin ameliorates chemically induced liver fibrosis in vivo and inhibits stellate cell proliferation in vitro by suppressing Wnt/&#x003B2;-catenin signaling</article-title><source>Toxicol Appl Pharmacol</source><volume>277</volume><fpage>210</fpage><lpage>220</lpage><year>2014</year><pub-id pub-id-type="doi">10.1016/j.taap.2014.03.008</pub-id><pub-id pub-id-type="pmid">24657339</pub-id></element-citation></ref>
<ref id="b20-ijmm-39-03-0672"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ganguli</surname><given-names>A</given-names></name><name><surname>Das</surname><given-names>A</given-names></name><name><surname>Nag</surname><given-names>D</given-names></name><name><surname>Bhattacharya</surname><given-names>S</given-names></name><name><surname>Chakrabarti</surname><given-names>G</given-names></name></person-group><article-title>Potential role of autophagy in smokeless tobacco extract-induced cytotoxicity and in morin-induced protection in oral epithelial cells</article-title><source>Food Chem Toxicol</source><volume>90</volume><fpage>160</fpage><lpage>170</lpage><year>2016</year><pub-id pub-id-type="doi">10.1016/j.fct.2016.02.011</pub-id><pub-id pub-id-type="pmid">26891815</pub-id></element-citation></ref>
<ref id="b21-ijmm-39-03-0672"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paoli</surname><given-names>P</given-names></name><name><surname>Cirri</surname><given-names>P</given-names></name><name><surname>Caselli</surname><given-names>A</given-names></name><name><surname>Ranaldi</surname><given-names>F</given-names></name><name><surname>Bruschi</surname><given-names>G</given-names></name><name><surname>Santi</surname><given-names>A</given-names></name><name><surname>Camici</surname><given-names>G</given-names></name></person-group><article-title>The insulin-mimetic effect of Morin: A promising molecule in diabetes treatment</article-title><source>Biochim Biophys Acta</source><volume>1830</volume><fpage>3102</fpage><lpage>3111</lpage><year>2013</year><pub-id pub-id-type="doi">10.1016/j.bbagen.2013.01.017</pub-id><pub-id pub-id-type="pmid">23352912</pub-id></element-citation></ref>
<ref id="b22-ijmm-39-03-0672"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sendrayaperumal</surname><given-names>V</given-names></name><name><surname>Iyyam Pillai</surname><given-names>S</given-names></name><name><surname>Subramanian</surname><given-names>S</given-names></name></person-group><article-title>Design, synthesis and characterization of zinc-morin, a metal flavonol complex and evaluation of its antidiabetic potential in HFD-STZ induced type 2 diabetes in rats</article-title><source>Chem Biol Interact</source><volume>219</volume><fpage>9</fpage><lpage>17</lpage><year>2014</year><pub-id pub-id-type="doi">10.1016/j.cbi.2014.05.003</pub-id><pub-id pub-id-type="pmid">24854284</pub-id></element-citation></ref>
<ref id="b23-ijmm-39-03-0672"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qureshi</surname><given-names>AA</given-names></name><name><surname>Guan</surname><given-names>XQ</given-names></name><name><surname>Reis</surname><given-names>JC</given-names></name><name><surname>Papasian</surname><given-names>CJ</given-names></name><name><surname>Jabre</surname><given-names>S</given-names></name><name><surname>Morrison</surname><given-names>DC</given-names></name><name><surname>Qureshi</surname><given-names>N</given-names></name></person-group><article-title>Inhibition of nitric oxide and inflammatory cytokines in LPS-stimulated murine macrophages by resveratrol, a potent proteasome inhibitor</article-title><source>Lipids Health Dis</source><volume>11</volume><fpage>76</fpage><year>2012</year><pub-id pub-id-type="doi">10.1186/1476-511X-11-76</pub-id><pub-id pub-id-type="pmid">22698256</pub-id><pub-id pub-id-type="pmcid">3393619</pub-id></element-citation></ref>
<ref id="b24-ijmm-39-03-0672"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dhanasekar</surname><given-names>C</given-names></name><name><surname>Kalaiselvan</surname><given-names>S</given-names></name><name><surname>Rasool</surname><given-names>M</given-names></name></person-group><article-title>Morin, a bioflavonoid suppresses monosodium urate crystal-induced inflammatory immune response in RAW 264.7 macrophages through the inhibition of inflammatory mediators, intracellular ROS levels and NF-&#x003BA;B activation</article-title><source>PLoS One</source><volume>10</volume><fpage>e0145093</fpage><year>2015</year><pub-id pub-id-type="doi">10.1371/journal.pone.0145093</pub-id></element-citation></ref>
<ref id="b25-ijmm-39-03-0672"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dilshara</surname><given-names>MG</given-names></name><name><surname>Jayasooriya</surname><given-names>RG</given-names></name><name><surname>Lee</surname><given-names>S</given-names></name><name><surname>Choi</surname><given-names>YH</given-names></name><name><surname>Kim</surname><given-names>GY</given-names></name></person-group><article-title>Morin downregulates nitric oxide and prostaglandin E<sub>2</sub> production in LPS-stimulated BV2 microglial cells by suppressing NF-&#x003BA;B activity and activating HO-1 induction</article-title><source>Environ Toxicol Pharmacol</source><volume>44</volume><fpage>62</fpage><lpage>68</lpage><year>2016</year><pub-id pub-id-type="doi">10.1016/j.etap.2016.04.010</pub-id><pub-id pub-id-type="pmid">27131287</pub-id></element-citation></ref>
<ref id="b26-ijmm-39-03-0672"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gupta</surname><given-names>SC</given-names></name><name><surname>Phromnoi</surname><given-names>K</given-names></name><name><surname>Aggarwal</surname><given-names>BB</given-names></name></person-group><article-title>Morin inhibits STAT3 tyrosine 705 phosphorylation in tumor cells through activation of protein tyrosine phosphatase SHP1</article-title><source>Biochem Pharmacol</source><volume>85</volume><fpage>898</fpage><lpage>912</lpage><year>2013</year><pub-id pub-id-type="doi">10.1016/j.bcp.2012.12.018</pub-id><pub-id pub-id-type="pmid">23279849</pub-id></element-citation></ref>
<ref id="b27-ijmm-39-03-0672"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manna</surname><given-names>SK</given-names></name><name><surname>Aggarwal</surname><given-names>RS</given-names></name><name><surname>Sethi</surname><given-names>G</given-names></name><name><surname>Aggarwal</surname><given-names>BB</given-names></name><name><surname>Ramesh</surname><given-names>GT</given-names></name></person-group><article-title>Morin (3,5,7,2&#x02032;,4&#x02032;-pentahydroxyflavone) abolishes nuclear factor-kappaB activation induced by various carcinogens and inflammatory stimuli, leading to suppression of nuclear factor-kappaB-regulated gene expression and up-regulation of apoptosis</article-title><source>Clin Cancer Res</source><volume>13</volume><fpage>2290</fpage><lpage>2297</lpage><year>2007</year><pub-id pub-id-type="doi">10.1158/1078-0432.CCR-06-2394</pub-id><pub-id pub-id-type="pmid">17404114</pub-id><pub-id pub-id-type="pmcid">2740379</pub-id></element-citation></ref>
<ref id="b28-ijmm-39-03-0672"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>C</given-names></name><name><surname>Lee</surname><given-names>WS</given-names></name><name><surname>Go</surname><given-names>SI</given-names></name><name><surname>Nagappan</surname><given-names>A</given-names></name><name><surname>Han</surname><given-names>MH</given-names></name><name><surname>Hong</surname><given-names>SH</given-names></name><name><surname>Kim</surname><given-names>GS</given-names></name><name><surname>Kim</surname><given-names>GY</given-names></name><name><surname>Kwon</surname><given-names>TK</given-names></name><name><surname>Ryu</surname><given-names>CH</given-names></name><etal/></person-group><article-title>Morin, a flavonoid from Moraceae, induces apoptosis by induction of BAD protein in human leukemic cells</article-title><source>Int J Mol Sci</source><volume>16</volume><fpage>645</fpage><lpage>659</lpage><year>2014</year><pub-id pub-id-type="doi">10.3390/ijms16010645</pub-id></element-citation></ref>
<ref id="b29-ijmm-39-03-0672"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hyun</surname><given-names>HB</given-names></name><name><surname>Lee</surname><given-names>WS</given-names></name><name><surname>Go</surname><given-names>SI</given-names></name><name><surname>Nagappan</surname><given-names>A</given-names></name><name><surname>Park</surname><given-names>C</given-names></name><name><surname>Han</surname><given-names>MH</given-names></name><name><surname>Hong</surname><given-names>SH</given-names></name><name><surname>Kim</surname><given-names>G</given-names></name><name><surname>Kim</surname><given-names>GY</given-names></name><name><surname>Cheong</surname><given-names>J</given-names></name><etal/></person-group><article-title>The flavonoid morin from Moraceae induces apoptosis by modulation of Bcl-2 family members and Fas receptor in HCT 116 cells</article-title><source>Int J Oncol</source><volume>46</volume><fpage>2670</fpage><lpage>2678</lpage><year>2015</year><pub-id pub-id-type="pmid">25892545</pub-id></element-citation></ref>
<ref id="b30-ijmm-39-03-0672"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>JY</given-names></name><name><surname>Kang</surname><given-names>KA</given-names></name><name><surname>Kim</surname><given-names>KC</given-names></name><name><surname>Cha</surname><given-names>JW</given-names></name><name><surname>Kim</surname><given-names>EH</given-names></name><name><surname>Hyun</surname><given-names>JW</given-names></name></person-group><article-title>Morin induces heme oxygenase-1 via ERK-Nrf2 signaling pathway</article-title><source>J Cancer Prev</source><volume>18</volume><fpage>249</fpage><lpage>256</lpage><year>2013</year><pub-id pub-id-type="doi">10.15430/JCP.2013.18.3.249</pub-id></element-citation></ref>
<ref id="b31-ijmm-39-03-0672"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rizvi</surname><given-names>F</given-names></name><name><surname>Mathur</surname><given-names>A</given-names></name><name><surname>Kakkar</surname><given-names>P</given-names></name></person-group><article-title>Morin mitigates acetaminophen-induced liver injury by potentiating Nrf2 regulated survival mechanism through molecular intervention in PHLPP2-Akt-Gsk3&#x003B2; axis</article-title><source>Apoptosis</source><volume>20</volume><fpage>1296</fpage><lpage>1306</lpage><year>2015</year><pub-id pub-id-type="doi">10.1007/s10495-015-1160-y</pub-id><pub-id pub-id-type="pmid">26286854</pub-id></element-citation></ref>
<ref id="b32-ijmm-39-03-0672"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mathur</surname><given-names>A</given-names></name><name><surname>Rizvi</surname><given-names>F</given-names></name><name><surname>Kakkar</surname><given-names>P</given-names></name></person-group><article-title>PHLPP2 down regulation influences nuclear Nrf2 stability via Akt-1/Gsk3&#x003B2;/Fyn kinase axis in acetaminophen induced oxidative renal toxicity: Protection accorded by morin</article-title><source>Food Chem Toxicol</source><volume>89</volume><fpage>19</fpage><lpage>31</lpage><year>2016</year><pub-id pub-id-type="doi">10.1016/j.fct.2016.01.001</pub-id><pub-id pub-id-type="pmid">26767949</pub-id></element-citation></ref>
<ref id="b33-ijmm-39-03-0672"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>YJ</given-names></name><name><surname>Koh</surname><given-names>EK</given-names></name><name><surname>Kim</surname><given-names>JE</given-names></name><name><surname>Go</surname><given-names>J</given-names></name><name><surname>Song</surname><given-names>SH</given-names></name><name><surname>Seong</surname><given-names>JE</given-names></name><name><surname>Son</surname><given-names>HJ</given-names></name><name><surname>Kang</surname><given-names>BC</given-names></name><name><surname>Hwang</surname><given-names>DY</given-names></name></person-group><article-title>Beneficial effects of ethanol extracts of Red Liriope platyphylla on vascular dysfunction in the aorta of spontaneously hypertensive rats</article-title><source>Lab Anim Res</source><volume>31</volume><fpage>13</fpage><lpage>23</lpage><year>2015</year><pub-id pub-id-type="doi">10.5625/lar.2015.31.1.13</pub-id><pub-id pub-id-type="pmid">25806079</pub-id><pub-id pub-id-type="pmcid">4371473</pub-id></element-citation></ref>
<ref id="b34-ijmm-39-03-0672"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sreejayan</surname><given-names>N</given-names></name><name><surname>Rao</surname><given-names>MN</given-names></name></person-group><article-title>Nitric oxide scavenging by curcuminoids</article-title><source>J Pharm Pharmacol</source><volume>49</volume><fpage>105</fpage><lpage>107</lpage><year>1997</year><pub-id pub-id-type="doi">10.1111/j.2042-7158.1997.tb06761.x</pub-id><pub-id pub-id-type="pmid">9120760</pub-id></element-citation></ref>
<ref id="b35-ijmm-39-03-0672"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>SH</given-names></name><name><surname>Kang</surname><given-names>SH</given-names></name><name><surname>Kang</surname><given-names>BS</given-names></name></person-group><article-title>Therapeutic effects of dihydroartemisinin and transferrin against glioblastoma</article-title><source>Nutr Res Pract</source><volume>10</volume><fpage>393</fpage><lpage>397</lpage><year>2016</year><pub-id pub-id-type="doi">10.4162/nrp.2016.10.4.393</pub-id><pub-id pub-id-type="pmid">27478545</pub-id><pub-id pub-id-type="pmcid">4958641</pub-id></element-citation></ref>
<ref id="b36-ijmm-39-03-0672"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eom</surname><given-names>SA</given-names></name><name><surname>Kim</surname><given-names>DW</given-names></name><name><surname>Shin</surname><given-names>MJ</given-names></name><name><surname>Ahn</surname><given-names>EH</given-names></name><name><surname>Chung</surname><given-names>SY</given-names></name><name><surname>Sohn</surname><given-names>EJ</given-names></name><name><surname>Jo</surname><given-names>HS</given-names></name><name><surname>Jeon</surname><given-names>SJ</given-names></name><name><surname>Kim</surname><given-names>DS</given-names></name><name><surname>Kwon</surname><given-names>HY</given-names></name><etal/></person-group><article-title>Protective effects of PEP-1-Catalase on stress-induced cellular toxicity and MPTP-induced Parkinson's disease</article-title><source>BMB Rep</source><volume>48</volume><fpage>395</fpage><lpage>400</lpage><year>2015</year><pub-id pub-id-type="doi">10.5483/BMBRep.2015.48.7.197</pub-id><pub-id pub-id-type="pmcid">4577289</pub-id></element-citation></ref>
<ref id="b37-ijmm-39-03-0672"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chun</surname><given-names>SK</given-names></name><name><surname>Go</surname><given-names>K</given-names></name><name><surname>Yang</surname><given-names>MJ</given-names></name><name><surname>Zendejas</surname><given-names>I</given-names></name><name><surname>Behrns</surname><given-names>KE</given-names></name><name><surname>Kim</surname><given-names>JS</given-names></name></person-group><article-title>Autophagy in ischemic livers: A critical role of Sirtuin 1/Mitofusin 2 axis in autophagy induction</article-title><source>Toxicol Res</source><volume>32</volume><fpage>35</fpage><lpage>46</lpage><year>2016</year><pub-id pub-id-type="doi">10.5487/TR.2016.32.1.035</pub-id><pub-id pub-id-type="pmid">26977257</pub-id><pub-id pub-id-type="pmcid">4780240</pub-id></element-citation></ref>
<ref id="b38-ijmm-39-03-0672"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alaoui-Jamali</surname><given-names>MA</given-names></name><name><surname>Bismar</surname><given-names>TA</given-names></name><name><surname>Gupta</surname><given-names>A</given-names></name><name><surname>Szarek</surname><given-names>WA</given-names></name><name><surname>Su</surname><given-names>J</given-names></name><name><surname>Song</surname><given-names>W</given-names></name><name><surname>Xu</surname><given-names>Y</given-names></name><name><surname>Xu</surname><given-names>B</given-names></name><name><surname>Liu</surname><given-names>G</given-names></name><name><surname>Vlahakis</surname><given-names>JZ</given-names></name><etal/></person-group><article-title>A novel experimental heme oxygenase-1-targeted therapy for hormone-refractory prostate cancer</article-title><source>Cancer Res</source><volume>69</volume><fpage>8017</fpage><lpage>8024</lpage><year>2009</year><pub-id pub-id-type="doi">10.1158/0008-5472.CAN-09-0419</pub-id><pub-id pub-id-type="pmid">19808972</pub-id></element-citation></ref>
<ref id="b39-ijmm-39-03-0672"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hensley</surname><given-names>P</given-names></name><name><surname>Mishra</surname><given-names>M</given-names></name><name><surname>Kyprianou</surname><given-names>N</given-names></name></person-group><article-title>Targeting caspases in cancer therapeutics</article-title><source>Biol Chem</source><volume>394</volume><fpage>831</fpage><lpage>843</lpage><year>2013</year><pub-id pub-id-type="doi">10.1515/hsz-2013-0128</pub-id><pub-id pub-id-type="pmid">23509217</pub-id><pub-id pub-id-type="pmcid">3721733</pub-id></element-citation></ref>
<ref id="b40-ijmm-39-03-0672"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>MacKenzie</surname><given-names>SH</given-names></name><name><surname>Clark</surname><given-names>AC</given-names></name></person-group><article-title>Targeting cell death in tumors by activating caspases</article-title><source>Curr Cancer Drug Targets</source><volume>8</volume><fpage>98</fpage><lpage>109</lpage><year>2008</year><pub-id pub-id-type="doi">10.2174/156800908783769391</pub-id><pub-id pub-id-type="pmid">18336192</pub-id><pub-id pub-id-type="pmcid">3119715</pub-id></element-citation></ref>
<ref id="b41-ijmm-39-03-0672"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lazebnik</surname><given-names>YA</given-names></name><name><surname>Kaufmann</surname><given-names>SH</given-names></name><name><surname>Desnoyers</surname><given-names>S</given-names></name><name><surname>Poirier</surname><given-names>GG</given-names></name><name><surname>Earnshaw</surname><given-names>WC</given-names></name></person-group><article-title>Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE</article-title><source>Nature</source><volume>371</volume><fpage>346</fpage><lpage>347</lpage><year>1994</year><pub-id pub-id-type="doi">10.1038/371346a0</pub-id><pub-id pub-id-type="pmid">8090205</pub-id></element-citation></ref>
<ref id="b42-ijmm-39-03-0672"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Azqueta</surname><given-names>A</given-names></name><name><surname>Slyskova</surname><given-names>J</given-names></name><name><surname>Langie</surname><given-names>SA</given-names></name><name><surname>O'Neill Gaiv&#x000E3;o</surname><given-names>I</given-names></name><name><surname>Collins</surname><given-names>A</given-names></name></person-group><article-title>Comet assay to measure DNA repair: Approach and applications</article-title><source>Front Genet</source><volume>5</volume><fpage>288</fpage><year>2014</year><pub-id pub-id-type="doi">10.3389/fgene.2014.00288</pub-id><pub-id pub-id-type="pmid">25202323</pub-id><pub-id pub-id-type="pmcid">4142706</pub-id></element-citation></ref>
<ref id="b43-ijmm-39-03-0672"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rogakou</surname><given-names>EP</given-names></name><name><surname>Pilch</surname><given-names>DR</given-names></name><name><surname>Orr</surname><given-names>AH</given-names></name><name><surname>Ivanova</surname><given-names>VS</given-names></name><name><surname>Bonner</surname><given-names>WM</given-names></name></person-group><article-title>DNA double-stranded breaks induce histone H2AX phosphory-lation on serine 139</article-title><source>J Biol Chem</source><volume>273</volume><fpage>5858</fpage><lpage>5868</lpage><year>1998</year><pub-id pub-id-type="doi">10.1074/jbc.273.10.5858</pub-id><pub-id pub-id-type="pmid">9488723</pub-id></element-citation></ref>
<ref id="b44-ijmm-39-03-0672"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dinkova-Kostova</surname><given-names>AT</given-names></name><name><surname>Holtzclaw</surname><given-names>WD</given-names></name><name><surname>Cole</surname><given-names>RN</given-names></name><name><surname>Itoh</surname><given-names>K</given-names></name><name><surname>Wakabayashi</surname><given-names>N</given-names></name><name><surname>Katoh</surname><given-names>Y</given-names></name><name><surname>Yamamoto</surname><given-names>M</given-names></name><name><surname>Talalay</surname><given-names>P</given-names></name></person-group><article-title>Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants</article-title><source>Proc Natl Acad Sci USA</source><volume>99</volume><fpage>11908</fpage><lpage>11913</lpage><year>2002</year><pub-id pub-id-type="doi">10.1073/pnas.172398899</pub-id><pub-id pub-id-type="pmid">12193649</pub-id><pub-id pub-id-type="pmcid">129367</pub-id></element-citation></ref>
<ref id="b45-ijmm-39-03-0672"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gan</surname><given-names>L</given-names></name><name><surname>Johnson</surname><given-names>JA</given-names></name></person-group><article-title>Oxidative damage and the Nrf2-ARE pathway in neurodegenerative diseases</article-title><source>Biochim Biophys Acta</source><volume>1842</volume><fpage>1208</fpage><lpage>1218</lpage><year>2014</year><pub-id pub-id-type="doi">10.1016/j.bbadis.2013.12.011</pub-id><pub-id pub-id-type="pmid">24382478</pub-id></element-citation></ref>
<ref id="b46-ijmm-39-03-0672"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Yang</surname><given-names>J</given-names></name><name><surname>Yi</surname><given-names>J</given-names></name></person-group><article-title>Redox sensing by proteins: Oxidative modifications on cysteines and the consequent events</article-title><source>Antioxid Redox Signal</source><volume>16</volume><fpage>649</fpage><lpage>657</lpage><year>2012</year><pub-id pub-id-type="doi">10.1089/ars.2011.4313</pub-id></element-citation></ref>
<ref id="b47-ijmm-39-03-0672"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clerkin</surname><given-names>JS</given-names></name><name><surname>Naughton</surname><given-names>R</given-names></name><name><surname>Quiney</surname><given-names>C</given-names></name><name><surname>Cotter</surname><given-names>TG</given-names></name></person-group><article-title>Mechanisms of ROS modulated cell survival during carcinogenesis</article-title><source>Cancer Lett</source><volume>266</volume><fpage>30</fpage><lpage>36</lpage><year>2008</year><pub-id pub-id-type="doi">10.1016/j.canlet.2008.02.029</pub-id><pub-id pub-id-type="pmid">18372105</pub-id></element-citation></ref>
<ref id="b48-ijmm-39-03-0672"><label>48</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jaramillo</surname><given-names>MC</given-names></name><name><surname>Zhang</surname><given-names>DD</given-names></name></person-group><article-title>The emerging role of the Nrf2-Keap1 signaling pathway in cancer</article-title><source>Genes Dev</source><volume>27</volume><fpage>2179</fpage><lpage>2191</lpage><year>2013</year><pub-id pub-id-type="doi">10.1101/gad.225680.113</pub-id><pub-id pub-id-type="pmid">24142871</pub-id><pub-id pub-id-type="pmcid">3814639</pub-id></element-citation></ref>
<ref id="b49-ijmm-39-03-0672"><label>49</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaspar</surname><given-names>JW</given-names></name><name><surname>Jaiswal</surname><given-names>AK</given-names></name></person-group><article-title>Tyrosine phosphorylation controls nuclear export of Fyn, allowing Nrf2 activation of cytoprotective gene expression</article-title><source>FASEB J</source><volume>25</volume><fpage>1076</fpage><lpage>1087</lpage><year>2011</year><pub-id pub-id-type="doi">10.1096/fj.10-171553</pub-id><pub-id pub-id-type="pmcid">3042843</pub-id></element-citation></ref>
<ref id="b50-ijmm-39-03-0672"><label>50</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jain</surname><given-names>AK</given-names></name><name><surname>Jaiswal</surname><given-names>AK</given-names></name></person-group><article-title>Phosphorylation of tyrosine 568 controls nuclear export of Nrf2</article-title><source>J Biol Chem</source><volume>281</volume><fpage>12132</fpage><lpage>12142</lpage><year>2006</year><pub-id pub-id-type="doi">10.1074/jbc.M511198200</pub-id><pub-id pub-id-type="pmid">16513647</pub-id></element-citation></ref></ref-list></back>
<floats-group>
<fig id="f1-ijmm-39-03-0672" position="float">
<label>Figure 1</label>
<caption>
<p>(A) Superoxide dismutase SOD-like and (B) ABTS radical scavenging activities of morin in comparison with vitamin C (Vit. C). Values are expressed as the mean &#x000B1; standard deviation of three replicates.</p></caption>
<graphic xlink:href="IJMM-39-03-0672-g00.tif"/></fig>
<fig id="f2-ijmm-39-03-0672" position="float">
<label>Figure 2</label>
<caption>
<p>Effects of morin on the cell viability and H<sub>2</sub>O<sub>2</sub>-induced growth inhibition of V79-4 lung fibroblasts. The cells were treated with (A) various concentrations of morin for 24 h or (B) pretreated with 500 <italic>&#x003BC;</italic>M morin or 10 mM NAC for 1 h and then incubated with or without 1 mM H<sub>2</sub>O<sub>2</sub> for 24 h. Cell viability was assessed using an MTT reduction assay. The results are presented as the mean &#x000B1; standard deviation values obtained from three independent experiments (<sup>&#x0002A;</sup>P&lt;0.05 compared with the control group; <sup>#</sup>P&lt;0.05 compared with the H<sub>2</sub>O-treated group).</p></caption>
<graphic xlink:href="IJMM-39-03-0672-g01.tif"/></fig>
<fig id="f3-ijmm-39-03-0672" position="float">
<label>Figure 3</label>
<caption>
<p>Protection against H<sub>2</sub>O<sub>2</sub>-induced apoptosis by treatment of V79-4 lung fibroblasts with morin. Cells were pretreated with 500 <italic>&#x003BC;</italic>M morin or 10 mM NAC for 1 h and then incubated with or without 1 mM H<sub>2</sub>O<sub>2</sub> for 24 h. (A) The cells were fixed and stained with DAPI solution. The stained nuclei were observed under a fluorescence microscope (x400, original magnification). (B) To quantify the degree of apoptosis, the cells were stained with Annexin V-FITC and PI, and the percentages of apoptotic cells (Annexin V<sup>+</sup>/PI<sup>&#x02212;</sup> cells) were then analyzed using flow cytometric analysis. The data shown represent the mean values found in two different experiments. NAC, <italic>N</italic>-acetyl-L-cysteine; PI, propidium iodide.</p></caption>
<graphic xlink:href="IJMM-39-03-0672-g02.tif"/></fig>
<fig id="f4-ijmm-39-03-0672" position="float">
<label>Figure 4</label>
<caption>
<p>Inhibition of H<sub>2</sub>O<sub>2</sub>-induced generation of ROS, loss of MMP and activation of caspase-3 by morin in V79-4 lung fibroblasts. The cells were pretreated with 500 <italic>&#x003BC;</italic>M morin for 1 h and then incubated with or without 1 mM H<sub>2</sub>O<sub>2</sub> for (A) 1 h or (B and C) 24 h. (A) To monitor ROS production, the cells were incubated at 37&#x000B0;C in the dark for 20 min with a new culture medium containing 10 <italic>&#x003BC;</italic>M DCF-DA. ROS accumulation was measured using a flow cytometer. (B) To assess the effects of morin on the H<sub>2</sub>O<sub>2</sub>-induced loss of MMP, the cells were collected and incubated with 10 <italic>&#x003BC;</italic>M JC-1 for 20 min at 37&#x000B0;C in the dark. The cells were then washed once with PBS and analyzed using a flow cytometer. The data shown represent the mean values from two different experiments. (C) To assess caspase-3 and PARP levels, the cells were lysed, and then equal amounts of cell lysates were separated using sodium dodecyl sulphate-polyacrylamide gel electrophoresis and transferred to PVDF membranes. The membranes were probed with anti-caspase-3 and anti-PARP antibodies, and the proteins were visualized using an ECL detection system. The relative ratios of expression as determined by the western blotting are presented at the bottom of each lane as relative values of actin expression. MMP, mitochondrial membrane potential; NAC, <italic>N</italic>-acetyl-L-cysteine; PVDF; polyvinylidene fluoride; PARP, poly(ADP-ribose) polymerase; ECL, enhanced chemiluminescence.</p></caption>
<graphic xlink:href="IJMM-39-03-0672-g03.tif"/></fig>
<fig id="f5-ijmm-39-03-0672" position="float">
<label>Figure 5</label>
<caption>
<p>Inhibition of H<sub>2</sub>O<sub>2</sub>-induced DNA damage by morin in V79-4 lung fibroblasts. Cells were pretreated with 500 <italic>&#x003BC;</italic>M morin or 10 mM NAC for 1 h and then incubated with or without 1 mM H<sub>2</sub>O<sub>2</sub> for 24 h. (A) To detect cellular DNA damage, the comet assay was performed and representative images of the comets were captured using a fluorescence microscope (x200, original magnification). (B) The cells were lysed and then equal amounts of cell lysates were separated on sodium dodecyl sulphate-polyacrylamide gel electrophoresis and transferred to PVDF membranes. The membranes were probed with specific antibodies against p-&#x003B3;H2AX, &#x003B3;H2AX and actin (internal control), and the proteins were visualized using an ECL detection system. The relative ratios of expression as determined by western blotting are presented at the bottom of each lane as relative values of actin expression. NAC, <italic>N</italic>-acetyl-L-cysteine; PVDF, polyvinylidene fluoride; ECL, enhanced chemiluminescence.</p></caption>
<graphic xlink:href="IJMM-39-03-0672-g04.tif"/></fig>
<fig id="f6-ijmm-39-03-0672" position="float">
<label>Figure 6</label>
<caption>
<p>Effects of morin on the expression of Nrf2 signaling-related proteins and activity of HO-1 in V79-4 lung fibroblasts. (A) The cells were incubated with 500 <italic>&#x003BC;</italic>M morin for the indicated time period. Cellular proteins were separated using sodium dodecyl sulphate-polyacrylamide gel electrophoresis and then transferred onto PVDF membranes. The membranes were probed with specific antibodies against Nrf2, p-Nrf2, HO-1, NQO-1 and Keap1. Proteins were visualized using an ECL detection system. Actin was used as an internal control. The relative ratios of expression as determine by western blotting are presented at the bottom of each lane as relative values of actin expression. (B) The HO activities of cells grown under the same conditions as (A) were determined based on bilirubin formation. Data represent the mean values from three independent experiments (<sup>&#x0002A;</sup>P&lt;0.05 compared with the control group). HO-1, heme oxygenase-1; Nrf2, nuclear factor-erythroid 2-related factor 2; ECL, enhanced chemiluminescence; PVDF, polyvinylidene fluoride.</p></caption>
<graphic xlink:href="IJMM-39-03-0672-g05.tif"/></fig>
<fig id="f7-ijmm-39-03-0672" position="float">
<label>Figure 7</label>
<caption>
<p>Effects of an HO-1 inhibitor on morin-mediated attenuation of MMP loss and growth inhibition by H<sub>2</sub>O<sub>2</sub> in V79-4 lung fibroblasts. The cells were pretreated for 1 h with 500 <italic>&#x003BC;</italic>M morin and then stimulated with or without 1 mM H<sub>2</sub>O<sub>2</sub> for a further 6 h in the absence or presence of 10 <italic>&#x003BC;</italic>M of ZnPP, an HO-1 inhibitor. (A and B) MMP was then determined. (C) Cell viability was then assessed. The results are expressed the mean &#x000B1; standard deviation of values obtained in three independent experiments (<sup>&#x0002A;</sup>P&lt;0.05 compared with the control group; <sup>#</sup>P&lt;0.05 compared with the H<sub>2</sub>O<sub>2</sub>-treated group; <sup>$</sup>P&lt;0.05 compared with the H<sub>2</sub>O<sub>2</sub> and morin-treated group). MMP, mitochondrial membrane potential; HO-1, heme oxygenase-1.</p></caption>
<graphic xlink:href="IJMM-39-03-0672-g06.tif"/></fig>
<table-wrap id="tI-ijmm-39-03-0672" position="float">
<label>Table I</label>
<caption>
<p>Antibodies used in the present study.</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th valign="top" align="left">Antibody</th>
<th valign="top" align="center">Origin</th>
<th valign="top" align="center">Company</th>
<th valign="top" align="center">Cat. no.</th></tr></thead>
<tbody>
<tr>
<td valign="top" align="left">Actin</td>
<td valign="top" align="left">Mouse monoclonal</td>
<td valign="top" align="left">Santa Cruz Biotechnology, Inc.</td>
<td valign="top" align="left">SC-47778</td></tr>
<tr>
<td valign="top" align="left">Caspase-3</td>
<td valign="top" align="left">Mouse monoclonal</td>
<td valign="top" align="left">Santa Cruz Biotechnology, Inc.</td>
<td valign="top" align="left">SC-7272</td></tr>
<tr>
<td valign="top" align="left">PARP</td>
<td valign="top" align="left">Rabbit polyclonal</td>
<td valign="top" align="left">Santa Cruz Biotechnology, Inc.</td>
<td valign="top" align="left">SC-7150</td></tr>
<tr>
<td valign="top" align="left">p-&#x003B3;H2AX</td>
<td valign="top" align="left">Rabbit monoclonal</td>
<td valign="top" align="left">Cell Signaling Technology, Inc.</td>
<td valign="top" align="left">9718</td></tr>
<tr>
<td valign="top" align="left">&#x003B3;H2AX</td>
<td valign="top" align="left">Rabbit monoclonal</td>
<td valign="top" align="left">Cell Signaling Technology, Inc.</td>
<td valign="top" align="left">7631</td></tr>
<tr>
<td valign="top" align="left">p-Nrf2</td>
<td valign="top" align="left">Rabbit monoclonal</td>
<td valign="top" align="left">Abcam, Inc.</td>
<td valign="top" align="left">ab76026</td></tr>
<tr>
<td valign="top" align="left">Nrf2</td>
<td valign="top" align="left">Rabbit polyclonal</td>
<td valign="top" align="left">Santa Cruz Biotechnology, Inc.</td>
<td valign="top" align="left">SC-13032</td></tr>
<tr>
<td valign="top" align="left">Keap1</td>
<td valign="top" align="left">Goat polyclonal</td>
<td valign="top" align="left">Santa Cruz Biotechnology, Inc.</td>
<td valign="top" align="left">SC-15246</td></tr>
<tr>
<td valign="top" align="left">HO-1</td>
<td valign="top" align="left">Rabbit polyclonal</td>
<td valign="top" align="left">Santa Cruz Biotechnology, Inc.</td>
<td valign="top" align="left">SC-10789</td></tr>
<tr>
<td valign="top" align="left">NQO1</td>
<td valign="top" align="left">Goat polyclonal</td>
<td valign="top" align="left">Santa Cruz Biotechnology, Inc.</td>
<td valign="top" align="left">SC-16464</td></tr></tbody></table></table-wrap></floats-group></article>
